Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors
Conditions: Acute Leukemia; Myelodysplastic Syndromes; Severe Aplastic Anemia Interventions: Drug: Sirolimus; Drug: Abatacept; Drug: MMF; Drug: ATG Sponsors: Peking University People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
Conditions: Rheumatoid Arthritis Interventions: Drug: Test Product; Drug: Reference product; Drug: Reference Medicinal Product Sponsors: Dr. Reddy ' s Laboratories Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy Participants
Condition: Healthy Participants Intervention: Biological: Abatacept Sponsor: Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
Subcutaneous Abatacept in Renal Transplant Recipients
Condition: Kidney Transplant Recipient Intervention: Drug: Abatacept 125Mg/Ml Syringe Sponsors: Idelberto Badell; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2023 Category: Research Source Type: clinical trials
